baber/WOPTO huggingface dataset:
Patent AU-2020294374-A1 (AU)
Title: Image decoding method for performing inter-prediction when prediction mode for current block ultimately cannot be selected, and device for same
Inventor: JANG HYEONGMOON
IPC: H04N19/513
Filed: 2020-06-19
Abstract: The present invention relates to an image decoding and encoding method which can efficiently perform inter-prediction by applying a regular merge mode to the current block on the basis of the case in which an MMVD mode, a merge sub-block mode, a CIIP mode, and a partitioning mode, in which prediction is performed by dividing the current block into two partitions, are not available for the current block.
Patent AU-2020356141-A1 (AU)
Title: Identification of health status in the elderly using immunological biomarkers
Inventor: BLACKBURN JONATHAN MICHAEL
IPC: G01N33/53
Filed: 2020-09-23
Abstract: A method for determining the health status of an elderly individual by testing the sample extracted from the individual for the presence of biomarkers, the bio markers being autoantibodies to antigens comprising MAPK13, CD96, FKBP3, PPM1A, PHLDA1, GLRX3, FEN1 and AURKA, wherein the antigens may further comprise one or more of UBE2I, AAK1, YARS, ASPSCR1, CASP10, FHOD2, TCL1A and MAP4, wherein PHLDA1 and CD96 correspond to healthy, AURKA, FEN1, CASP10 and AAK1 correspond to intermediate health, and UBE2I, YARS, ASPSCR1, FHOD2, TCL1A, MAP4, MAPK13, FKBP3, PPM1 A and GLRX3 correspond to unhealthy.
Patent AU-2020387408-A1 (AU)
Title: Systems, apparatus and methods for identifying and securely storing distinguishing characteristics in a distributed ledger within a distributed ledger-based network based on fungible and non-fungible tokens
Inventor: ROBOTHAM JOHN STODDARD
IPC: G06Q40/00
Filed: 2020-11-19
Abstract: In some embodiments, a method includes storing data associated with fungible assets in a distributed ledger database. The method includes dividing fungible tokens into a first set of groups of fungible tokens based on the data and sending, via the distributed ledger-based network and based on an asymmetric cryptography key pair, each group of fungible tokens from the first set of groups of fungible tokens to a communication device from the first set of communication devices to cause the second plurality of communication devices to send, to a designated recipient communication device, non-fungible tokens for each group of fungible tokens from the second set of groups of fungible tokens. The first set of groups of fungible tokens is divided into a second set of groups of fungible tokens and received at a second set of communication devices.
Patent AU-2020396050-A1 (AU)
Title: Real time mine monitoring system and method
Inventor: JOB ANDREW
IPC: G01S17/86
Filed: 2020-11-25
Abstract: The present invention relates to a method for detecting changes in the ore grade of a rock face in near real time. The method includes the step of providing a scanning system having at least a hyperspectral imager, a position system, a LiDAR or range determination unit and computational resources. Further, the method involves determining a precise location of the scanning system utilising the position system. The rock face is scanned with the range determination unit to determine rock face position information. The method involves scanning the rock face with the hyperspectral imager to produce a corresponding rock face hyperspectral image. Further the method involves utilising the computational resources to fuse together the rock face position information and the corresponding rock face hyperspectral image to produce a rock face position and content information map of the rock face.
Patent AU-2020400820-A1 (AU)
Title: Method and apparatus for sterilizing medical instruments
Inventor: VERHOEVEN FRANCISCUS MARIA
IPC: A61L2/14
Filed: 2020-12-08
Abstract: A method and apparatus for sterilizing a medical instrument, such as a dental instrument. The method includes placing the medical instrument in a chamber, providing a sterilizing agent including recombined ionized humidified air, controlling the temperature of the medical instrument and/or the chamber such that the temperature of the medical instrument is below the temperature of chamber, and at least partially condensing the sterilizing agent onto the instruments.
Patent AU-2020408301-A1 (AU)
Title: Method and kit for whole genome amplification and analysis of target molecules in a biological sample
Inventor: MANARESI NICOLÒ
IPC: C12Q1/6804
Filed: 2020-12-16
Abstract: There is disclosed a method for whole genome amplification and analysis of multiple target molecules in a biological sample including genomic DNA and target molecules comprising the steps of contacting the biological sample with at least one binding agent, directed to at least one of the target molecules, conjugated with a tagged oligonucleotide, which comprises a binding-agent barcode sequence (BAB) and a unique molecular identifier sequence (UMI); carrying out a separating step to selectively remove unbound binding agent thus obtaining a labeled biological sample; simultaneously carrying out on the labeled biological sample a whole genome amplification and an amplification of the tagged oligonucleotide; preparing a massively parallel sequencing library from the amplified tagged oligonucleotide; sequencing the massively parallel sequencing library; retrieving the sequences of the BAB and UMI from each sequencing read; counting the number of distinct UMI for each binding agent.
Patent AU-2020414412-A1 (AU)
Title: Enclosure for electrical installations
Inventor: WEBER KENNETH
IPC: H02B1/40
Filed: 2020-12-22
Abstract: The invention relates to an enclosure for electrical installations, the enclosure comprising a bottom part (1) and a cover part (2) fastened to the bottom part (1) by fastening means (3) comprising a latch (14) which, supported by a bearing, may be turned in relation to the bottom part (1) to open and close the fastening means (3), and a arm (5) which is bearing-mounted to the latch (14), whereby the cover (2) has a detent to receive the arm (5) and to fasten the cover to the bottom part (1) by means of the arm (5). In order for the enclosure getting dirty in use to not hinder fast opening of the enclosure and to have the external appearance of the enclosure smart at the fastening means (3), the detent is located in a recess formed in an edge of the cover (2), whereby attached to the arm (5) there is a cover piece (8) adapted to attach to the detent in the recess of the cover (2) whereby the cover piece (8) comprises a first outer surface and a second outer surface which at the recess of the cover make the outer surfaces of the cover uniform and such that the discontinuities formed by the recess of the cover on the top surface of the cover and correspondingly on the side surface of the cover are concealed.
Patent AU-2020415329-A1 (AU)
Title: Composition for treating or preventing an allergy or allergic reaction
Inventor: ANKERSMIT HENRIK JAN
IPC: C12N5/078
Filed: 2020-12-23
Abstract: The present invention relates to a composition comprising a supernatant of a peripheral blood mononuclear cell (PBMC) cell culture for use in the treatment or prevention of an allergy or an allergic reaction caused by the administration of at least one food and/or inhalation allergen or by the systemic administration of at least one drug to a human or mammal body.
Patent AU-2020416484-A1 (AU)
Title: Crystal form of pyridopyrimidine derivative and preparation method thereof
Inventor: WU QI
IPC: A61P31/18
Filed: 2020-12-31
Abstract: The present disclosure relates to a crystal form of a pyridopyrimidine derivative and a preparation method thereof, and specifically relates to the crystal form of the compound of formula (I) and a preparation method thereof. The new crystal form has good physical and chemical properties, thereby facilitating clinical treatments.
Patent AU-2020435783-A1 (AU)
Title: Beverage containing caffeine and sweet component
Inventor: NOBUTA MIKU
IPC: A23L2/52
Filed: 2020-12-14
Abstract: The present invention suppresses caffeine-caused reduction in sweetness in a beverage in which a sweet component and caffeine are blended. In the present invention, 4 to 40 mg/100 ml of γ-aminobutyric acid is blended in a beverage containing a sweet component and 3 to 45 mg/100ml of caffeine. The beverage has a pH of 2.0 to 5.5.
Patent AU-2020469388-A1 (AU)
Title: Techniques for pre and post forward error correction and packet padding in radio transmission
Inventor: SHILO SHIMON
IPC: H04W84/12
Filed: 2020-09-28
Abstract: The present disclosure relates to techniques for forward error correction and packet padding in radio transmission, e.g. WiFi communication schemes such as IEEE 802.11ax and 802.11be. In particular the disclosure relates to a communication device (100), configured to: transmit and/or receive a data frame based on a set of pre&post-Forward Error Correction, FEC, parameters and a set of packet extension, PE, parameters, wherein the set of pre&post-FEC parameters is based on an extension of a set of pre&post-FEC parameters defined for a second radio transmission technology with respect to a size of resource units, RUs, supported by a first radio transmission technology, wherein the set of pre&post-FEC parameters is based on a combination of RUs that is supported by the first radio transmission technology and wherein the set of PE parameters is based on an extension of a set of PE parameters defined for the second radio transmission technology.
Patent WO-2021159178-A1 (WO)
Title: Nanotube mediated delivery system and methods comprising the same
Inventor: VOELCKER NICOLAS HANS
IPC: B82Y5/00
Filed: 2021-02-10
Abstract: The present disclosure relates generally to a molecular delivery system and methods of using the molecular delivery system to deliver biomolecules into cells. In particular, the molecular delivery system comprises a nanotube (NT) array comprising a plurality of nanotubes (NTs) which are used to deliver biomolecules to cells. The NTs can be loaded with molecules that can be delivered into cells following contact (e.g. penetration) by the NTs.
Patent WO-2021174298-A1 (WO)
Inventor: WHITE ANDREW
IPC: A61M27/00
Filed: 2021-03-02
Abstract: An ocular implant (10) for conveying intraocular fluid away from a site of excess intraocular fluid within a patient, the implant (10) including: a body (12) including one or more drainage channels (20) each having an outlet (24) fluidly communicable with a drainage site located away from the site of excess intraocular fluid; and an elongated tubular member (30) fluidly communicable with the body (12), the member (30) having a first end portion (32) providing an inlet (38), a second end portion (34) providing an end (40), and a lumen extending between the inlet (38) and the end (40), wherein the inlet (38) is fluidly communicable with the site of excess intraocular fluid so that the intraocular fluid is able to flow past the inlet (38) and through the lumen towards the end (40), and wherein the second end portion (34) includes one or more openings (42) each fluidly communicable with a respective one of the one or more drainage channels (20) to permit the intraocular fluid to flow from the second end portion (34) to each of the outlets (24).
Patent WO-2022032349-A1 (WO)
Title: A solar innovation system
Inventor: FILA MICHAEL
IPC: B60L53/52
Filed: 2021-08-13
Abstract: The present invention relates to solar shades and car ports for vehicles. In one form, the solar shade for a vehicle includes at least one vertical member mountable to a support surface for supporting said vertical member in an erect position; a shade frame movably coupled to an upper end of the at least one vertical member and having a plurality of photovoltaic cells mounted thereon; an actuating mechanism for moving the shade frame between an operable and stowage positions; an energy storage system operatively associated with the at least one vertical member for receiving, regulating and storing electrical energy supplied from the plurality of photovoltaic cells; and a controller operatively associated with the actuating mechanism, said controller configured to monitor an environmental condition and activate the actuating mechanism to selectively move the shade frame to maximise sunlight exposure of the plurality of photovoltaic cells.
Patent WO-2022077073-A1 (WO)
Title: Agencements de commande de tamis vibrant
Inventor: TEYHAN DOUGLAS ROBERT
IPC: H02K7/065
Filed: 2021-10-15
Abstract: L'invention divulgue un appareil de tamisage vibratoire permettant de tamiser des matériaux de minerais extraits à l'aide d'une vibration elliptique, l'appareil comportant une section statique et une section dynamique comprenant un étage de tamisage ; l'appareil comporte trois paires de cellules d'excitation à mouvement rotatif, un premier groupe de trois desdites cellules d'excitation à mouvement rotatif étant positionné sur un premier côté de la section dynamique, et un second groupe de trois desdites cellules d'excitation à mouvement rotatif étant positionné sur un second côté de la section dynamique ; chaque cellule dans ledit premier groupe forme une paire avec une cellule respective parmi les cellules dans le second groupe ; l'appareil comprend en outre des moyens d'entraînement destinés à entraîner les cellules en rotation, et des moyens de synchronisation mécanique reliant la rotation d'une première paire de cellules à une seconde paire de cellules, grâce à quoi, lors de l'utilisation, la rotation desdites paires de cellules est synchronisée mécaniquement.
Patent AU-2021202163-A1 (AU)
Title: Methods and systems for inhibiting the spread of a pathogen
Inventor: GRISSEN Thomas
IPC: H04W4/029
Filed: 2021-04-08
Abstract: OF THE DISCLOSURE 
A method for inhibiting the spread of a pathogen is provided that includes storing, using a 
computer, location data of computing devices. Each computing device is associated with a 
respective user. The method also includes receiving data indicating one of the users contracted a 
pathogen, and comparing, using the computer, the location data of the computing device 
associated with the pathogenic user against the location data of the other computing devices to 
determine whether the computing device of the pathogenic user was within a distance of at least 
one other computing device within a period of time. When at least one other computing device 
was within the distance of the computing device associated with the pathogenic user, the user 
associated with the at least one other computing device is identified and notified.
3/3 
36 Start 38 
Storing location data 40 
Receiving data about pathogenic user 42 
No Proximate 44 
users 
? 
~Yes 
Identifying users 46 
Notifying users 48 
End 50 
FIG. 3
Patent AU-2021202296-A1 (AU)
Title: Genetically modified Cannabis sativa plants and modified cannabinoid compounds for treatment of substance addiction and other disorders
Inventor: WILLIAMS JONNIE R
IPC: C12N15/09
Filed: 2021-04-15
Abstract: OF THE DISCLOSURE 
A method of increasing the cannabinoid levels in a genetically modified Cannabis 
sativa plant includes genetically modifying the plant to induce the overexpression of the gene 
that controls the expression of tetrahydrocannabinolic acid (THCA) synthase and/or 
cannabidiolic acid (CBDA) synthase. The overexpression of THCA synthase and CBDA 
synthase catalyzes an increased synthesis of cannabigerolic acid to tetrahydrocannabinolic acid 
and cannabidiolic acid, as well as the cannabinoids (3aR)-2,4,4-trimethyl-7-pentyl-3,3a,4,9b
tetrahydrocyclopenta[c]chromen-9-ol and 2-((1R,5R)-3-methyl-5-(prop-I-en-2-yl)cyclopent
2-en-1-yl)-5-pentylbenzene-1,3-diol. Pharmaceutical compositions comprising the modified 
cannabinoids produced by the transgenic Cannabis sativa plant or prepared synthetically are 
used to treat various diseases and conditions.
Patent AU-2021203446-A1 (AU)
Title: Method and system for compliance monitoring
Inventor: GORDON JAMILA
IPC: G06V40/10
Filed: 2021-05-27
Abstract: Methods for compliance monitoring are provided. In one embodiment, a method 
includes identifying users from tracking identifiers and determining whether they 
comply with distancing requirements. In another embodiment, a method includes 
using two cameras to capture images of users in an environment and correlating 
predetermined user and environmental data to the images captured from each of 
these cameras to determine whether the users comply with distancing requirements.
rH 2/4 
c 0 
0 0 
u 
r'4 
oo 
7a C 
+1~ 
E co 
LUW 
4-.  
bD Co 
CJC 
C) 00 
0v 
-Er 
0 0 
C Ew 
o 05 
oi 0 
-c r
Patent AU-2021204514-A1 (AU)
Title: Theft-Resistant Deposit Box
Inventor: BOLLES DAVID J
IPC: A47G29/22
Filed: 2021-06-30
Abstract: A wall mount deposit box is provided. A housing includes a front side and a back side.  
A rotatable content deposit includes a content delivery door and an inner panel affixed on a 
proximate end at an angle to a bottom of the content delivery door, and is pivotably attached to 
5 the front side of the housing. A content slot is formed as an opening within a front surface of the 
housing when the rotatable content deposit is in a fully open position allowing content to be 
deposited through the opening over each of the inner panel and the safety arm. A content 
retrieval door is located below the rotatable content deposit and is pivotably attached to the front 
side of the housing.
Patent AU-2021232676-A1 (AU)
Title: Equipment connection device and electrical equipment
Inventor: YU HAIYANG
IPC: H01R12/00
Filed: 2021-09-14
Abstract: The present application discloses an equipment connection device and an electrical 
equipment, wherein the equipment connection device includes a buckle capable of connecting 
with an external connector and a fastener mounting plate capable of connecting with the 
buckle, the fastener mounting plate is capable of connecting with the external connector, and 
the buckle or the fastener mounting plate is configured to connect with the equipment body.  
When equipment installation is needed, the buckle or the fastener mounting plate is mounted 
on the equipment body, and the buckle is assembled with the fastener mounting plate. In the 
specific installation environment, the buckle or the fastener mounting plate is selected 
according to needs to connect with the external connector to realize the installation of the 
equipment body. In the equipment connection device provided by the present application, the 
equipment connection device is an assembly of the buckle and the fastener mounting plate. In 
specific use, the equipment may be mounted with the external environment through the 
buckle or the fastener mounting plate. Therefore, the versatility of the equipment connection 
device provided by the present application is improved.  
17
2 
L $9 
3 6' 
________________________j~2 
I I 
FIG.1 
2 
1 
I / 
I? II ii 
/ Ik~. / / 
/ 1 / T~='~~ 
I I / 
/ / / / 
/ / / I, /1 /// ./ I 
FIG.2 
- 1/9-
Patent AU-2021245184-A1 (AU)
Title: Il-1beta binding antibodies for use in treating cancer
Inventor: LIGUEROS-SAYLAN MONICA
IPC: A61K39/00
Filed: 2021-10-07
Abstract: Use of an IL- IPbinding antibody or a functional fragment thereof, especially canakinumab or 
5 a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers 
for the treatment and/or prevention of cancer with at least partial inflammatory basis.
Patent AU-2021246526-A1 (AU)
Title: Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (AATD)
Inventor: GIROUX SIMON
IPC: A61K31/35
Filed: 2021-04-02
Abstract: Indole derivatives as alpha-l-antitrypsin modulators for treating alpha-l-antitrypsin deficiency (AATD).
Patent AU-2021276709-A1 (AU)
Title: A method for the continuous generation and harvesting of biothermal energy
Inventor: BELLAMY KENNETH MICHAEL
IPC: F24V30/00
Filed: 2021-11-29
Abstract: A method for generating and capturing biothermal energy comprising: forming a heap 
comprising an amended organic material; subjecting the amended organic material to a 
continuous fermentation process to produce a convection current, and to stimulate capture of 
non-visible radiation, and using a heat exchanger in contact with the heap, capture and/or 
store biothermal energy generated by the continuous fermentation reaction within the heap.
1/1 
100 
10 
12 
%4eo 
14 
Figure 1 16 
200 Forming a heap comprising an 210 
amended organic material.  
Subjecting the amended organic 220 
material to a continuous fermentation 
process to produce a convection 
current and to stimulate the 
continuous capture of non-visible 
radiation.  
Using a heat exchanger in contact with 230 
the heap, capture and/or store 
biothermal energy generated by the 
continuous fermentation process 
within the heap.  
Figure 2
Patent AU-2021292668-A1 (AU)
Title: Sensitiser for cancer treatment
Inventor: NAVITA Somaiah
IPC: A61K31/728
Filed: 2021-06-14
Abstract: It is still unclear which usage amounts of cancer-treatment sensitisers and which methods of use thereof are effective for tumours and what timetable for cancer treatments such as radiotherapy or anti-cancer chemotherapy is effective after administering a sensitiser.　The inventors of the present invention solved this problem by demonstrating that, by injecting a specific amount of a cancer-treatment sensitiser, which is produced by combining H
Patent AU-2021293038-A1 (AU)
Title: Methods and compositions for treating triple-negative breast cancer
Inventor: NGUYEN DUC ANH
IPC: C07K16/28
Filed: 2021-06-15
Abstract: The invention provides methods and compositions (e.g., pharmaceutical compositions) for treating breast cancer (e.g., TNBC (e.g., eTNBC)) in a subject. In some aspects, the methods include administering a treatment regimen including a PD-1 axis binding antagonist (e.g., an anti-PD-L1 antibody (e.g., atezolizumab) or an anti-PD-1 antibody), a taxane (e.g., nab-paclitaxel or paclitaxel), an anthracycline (e.g., doxorubicin or epirubicin), and an alkylating agent (e.g., a nitrogen mustard derivative (e.g., cyclophosphamide)) to the subject. In some aspects, the treatment regimen increases the subject's likelihood of having a pathologic complete response (pCR) as compared to treatment with the taxane, the anthracycline, and the alkylating agent without the PD-1 axis binding antagonist. Also provided are pharmaceutical compositions for use in treating breast cancer (e.g., TNBC (e.g., eTNBC)) in a subject.
Patent AU-2021305665-A1 (AU)
Title: Methods and compositions for treating epilepsy
Inventor: CREPEL VALÉRIE
IPC: C12N15/113
Filed: 2021-07-09
Abstract: The present disclosure provides methods and compositions relating to gene therapy for treating epilepsy, such as a temporal lobe epilepsy, in a subject in need thereof by targeting
Patent AU-2021308797-A1 (AU)
Title: Cosmetic formulations for hair treatment with improved properties
Inventor: GOI PAOLO
IPC: A61Q5/02
Filed: 2021-07-14
Abstract: The present invention relates to the use of microfibrillated cellulose (MFC) as stabiliser, suspending agent and/or conditioner and/or filming agent and/or strengthener in hair-treatment formulations. Particular embodiments of the present invention are formulations such as shampoos, leave-on hair-conditioning balms, and products for dyeing hair.
Patent AU-2021319252-A1 (AU)
Title: Polypeptides RV3 and RV4 having anti-aging function and applications thereof
Inventor: XU HANMEI
IPC: A61K38/08
Filed: 2021-07-02
Abstract: Provided is a polypeptide capable of prolonging the life of Caenorhabditis elegans. The polypeptide has an amino acid sequence TX
Patent AU-2021331730-A1 (AU)
Title: Antitumor bacterial strain, and composition and method using same
Inventor: KIM YEUNG HYEN
IPC: A61K35/744
Filed: 2021-08-09
Abstract: The present invention relates to: